529 Reduced dendritic cell infiltration in anti-PD-1 resistant head and neck squamous cell carcinoma
529 Reduced dendritic cell infiltration in anti-PD-1 resistant head and neck squamous cell carcinoma
About this item
Full title
Author / Creator
Publisher
London: BMJ Publishing Group LTD
Journal title
Language
English
Formats
Publication information
Publisher
London: BMJ Publishing Group LTD
Subjects
More information
Scope and Contents
Contents
BackgroundAlthough immune checkpoint inhibitors have been approved for head and neck squamous cell carcinoma (HNSCC) patients, the majority do not respond, and further treatment optimization is required. Diverse anti-PD-1 resistance mechanisms have been proposed for this lack of benefit, which is inconsistent with the moderate tumor mutational burd...
Alternative Titles
Full title
529 Reduced dendritic cell infiltration in anti-PD-1 resistant head and neck squamous cell carcinoma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2835338037
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2835338037
Other Identifiers
E-ISSN
2051-1426
DOI
10.1136/jitc-2022-SITC2022.0529
